
News|Videos|May 4, 2026
ARVO 2026: Is Grok a valuable tool for patients?
Author(s)Martin David Harp
The poster looked into the LLM's potential for biases in gender and race when it came to its knowledge of retinitis pigmentosa.
Advertisement
Renee Long, from the University of California San Diego, took some time to discuss her poster on the viability of Grok as a tool for patients in ophthalmology. Long looked into the LLM's potential for biases in gender and race when it came to its knowledge of retinitis pigmentosa.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
SubscribeAdvertisement
Latest CME
Advertisement
Advertisement























